This high cost, along with limited manufacturing supply, means usage has remained mostly concentrated in wealthier countries (notably the US and parts of Europe) and among patients who can afford to pay
The company's 36-year operational history, A+ Better Business Bureau rating, and transparent business practices provide legitimacy verification in a market often characterized by questionable vendors and unverifiable quality claims
Future research should focus on large-scale, well-controlled randomized trials with standardized dosing protocols, clearly defined deficiency thresholds, and long-term follow-up to strengthen the evidence base and guide clinical practice
At $200$500 per month, a medically supervised GLP-1 program at Peak Performance is often less than what people are already spending on medications, supplements, meal delivery kits, and gym memberships that arent producing results
While 73% of Americans are either overweight or have obesity, there are open questions about the use of GLP-1s in people who are not overweight will these medications cause excess weight loss and, in particular, excess muscle loss
Currently, neither cagrilintide nor retatrutide is available through the NHS